J-Pharma Co (TSE:520A) Total Assets: 円2,952.46 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:520A J-Pharma Co Ltd TSE:520A
9 GF Score
Price 円290.00
View Full Analysis

What is J-Pharma Co Total Assets?

J-Pharma Co TSE:520A -2.36% 9 Total Assets is 円2,952.46 Mil as of Dec. 2025. GuruFocus rates TSE:520A with a GF Score™ of 9/100.

J-Pharma Co's Total Assets for the quarter that ended in Dec. 2025 was 円2,952.46 Mil.

During the past 12 months, J-Pharma Co's average Total Assets Growth Rate was 313.40% per year.

Total Assets is connected with ROA %. J-Pharma Co's annualized ROA % for the quarter that ended in Dec. 2025 was -61.69%. Total Assets is also linked to Revenue through Asset Turnover. J-Pharma Co's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

J-Pharma Co  (TSE:520A) Total Assets Explanation

Total Assets is connected with ROA %.

J-Pharma Co's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-1791.708/( (2856.719+2952.455)/ 2 )
=-1791.708/2904.587
=-61.69 %

Note: The Net Income data used here is four times the quarterly (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

J-Pharma Co's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0/( (2856.719+2952.455)/ 2 )
=0/2904.587
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

J-Pharma Co Total Assets Related Terms

J-Pharma Co Total Assets Historical Data

* Premium members only.

The historical data trend for J-Pharma Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

J-Pharma Co Total Assets Chart

J-Pharma Co Annual Data
Trend Mar24 Mar25
Total Assets
1,207.39 2,856.72

J-Pharma Co Quarterly Data
Mar24 Mar25 Dec25
Total Assets 1,207.39 2,856.72 2,952.46
TSE:520A
9GF Score
J-Pharma Co Ltd TSE:520A
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

J-Pharma Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

J-Pharma Co's Total Assets for the fiscal year that ended in Mar. 2025 is calculated as

Total Assets=Total Equity (A: Mar. 2025 )+Total Liabilities (A: Mar. 2025 )
=2377.869+478.85
=2,856.72

J-Pharma Co's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=2344.635+607.82
=2,952.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of 円2,952.46 Mil mean?
J-Pharma Co (TSE:520A) has a Total Assets of 円2,952.46 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on J-Pharma Co and its competitors.
Is J-Pharma Co's Total Assets too high?
J-Pharma Co's current Total Assets is 円2,952.46 Mil. Overall, J-Pharma Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does J-Pharma Co's Total Assets compare to VRTX and REGN?
J-Pharma Co's Total Assets of 円2,952.46 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on J-Pharma Co and its competitors. J-Pharma Co's current Total Assets is 円2,952.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J-Pharma Co stock overvalued right now?
J-Pharma Co (TSE:520A) has a current Total Assets of 円2,952.46 Mil. The current Total Assets is 円2,952.46 Mil. J-Pharma Co's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For J-Pharma Co (TSE:520A), the current Total Assets is 円2,952.46 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

J-Pharma Co Business Description

Address 1-10-11, HamamatsuCho, 8th floor, Minato-Ku, Tokyo, JPN, 105-0013
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
9GF Score

Get the complete analysis for TSE:520A

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円290.00
Price